TargetMol

GW2580

Product Code:
 
TAR-T2659
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2659-5mg5mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2659-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2659-10mg10mg£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2659-50mg50mg£134.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2659-100mg100mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2659-200mg200mg£183.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2659-500mg500mg£300.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
GW2580 is a specific, oral-bioavailable CSF-1R inhibitor for c-FMS.
CAS:
870483-87-7
Formula:
C20H22N4O3
Molecular Weight:
366.421
Pathway:
Tyrosine Kinase/Adaptors
Purity:
0.9948
SMILES:
COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1
Target:
c-Fms

References

1. Conway JG, et al. Proc Natl Acad Sci U S A, 2005, 102(44), 16078-16083. 2. Priceman SJ, et al. Blood, 2010, 115(7), 1461-1471 3. Conway JG, et al. J Pharmacol Exp Ther, 2008, 326(1), 41-50.